Exploring how stigma affects HIV treatment in diverse women who use drugs
Women, Intersectionality, Substance Use and HIV ( WISH)
This study is looking at how stigma and discrimination affect the health of racially diverse women living with HIV who use drugs, and it aims to find ways to help them get better care and support for their treatment.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10890761 on NIH RePORTER |
What this research studies
This research investigates the impact of intersectional stigma and discrimination on HIV treatment outcomes among racially diverse women living with HIV who use drugs. It aims to understand how these factors contribute to inequalities in care and how resilience can promote better engagement in HIV treatment. The study will adapt an existing evidence-based intervention to address these challenges and evaluate its acceptability and feasibility in San Francisco. By focusing on the unique experiences of these women, the research seeks to improve HIV care engagement.
Who could benefit from this research
Good fit: Ideal candidates for this research are racially diverse women living with HIV who also use drugs.
Not a fit: Patients who do not identify as women or do not have HIV may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved HIV treatment outcomes for racially diverse women who use drugs by addressing the barriers they face.
How similar studies have performed: Other research has shown success in using intersectional approaches to improve health outcomes, indicating potential for this study's approach.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Jain, Jennifer Payaal — University of California, San Francisco
- Study coordinator: Jain, Jennifer Payaal
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.